Six insights from the position statement:
1. Opioids should not be used as a first-line treatment for either acute or chronic hip or knee osteoarthritis symptoms.
2. When other non-opioid treatments have failed and patients cannot undergo joint replacement surgery, clinicians may consider opioid-use for a small subset of patients.
3. Patients who are prescribed opioids for nonoperative osteoarthritis treatment should receive education on the risks of prolonged opioid use, including addiction and dependency.
4. Physicians should prescribe the fewest number of opioids in the lowest does for the shortest possible time.
5. Providers should consider referring patients who require extended opioid-use to a pain management specialist.
6. Patients should receive education on the safe storage of opioid pain medications and proper disposal when prescriptions are no longer needed.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Eric Makhni of Henry Ford Health System
Delaware orthopedic practice welcomes Dr. Joseph Farrell: 3 things to know
Jefferson Health 3B Orthopaedics team completes Panama medical mission: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
